Table 1 of Stunf, Mol Vis 2012; 18:2909-2914.
Age at the time of AqH tap, gender | Vaccine against RV | Duration of uveitis before tap (years) | BCVA (Snellen) | Iris hetrochro-mia or atrophy* | KP* | Cata- ract* | IOL* | No syne- chia* | ** | Glau-coma* | Vitritis* | GWC | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
RV | HSV | VZV | CMV | Toxo | ||||||||||||
55, F | no | 13 | 1 | 0 | 1 | 0 | 1 | 1 | 3 | 1 | 1 | 44,65 | <3/Neg | <3/Neg | <3/Neg | <3/Neg |
43, F | 12 yo | 6 | 0,2 | 1 | 1 | 1 | 0 | 1 | 4 | 0 | 1 | 15,27 | <3/Neg | <3/Neg | <3/Neg | <3/Neg |
40, F | 12 yo | 3 | 1 | 1 | 1 | 0 | 0 | 1 | 3 | 0 | 1 | 38,06 | <3/Neg | <3/Neg | <3/Neg | <3/Neg |
50, M | no | 7 | 0,3 | 1 | 1 | 0 | 1 | 1 | 4 | 1 | 1 | 38,43 | <3/Neg | <3/Neg | <3/Neg | <3/Neg |
33, M | no | 3 | 0,5 | 1 | 1 | 1 | 0 | 1 | 4 | 0 | 1 | 7,78 | <3/Neg | <3/Neg | <3/Neg | <3/Neg |
71, M | no | 3 | 0,8 | 1 | 1 | 0 | 1 | 1 | 4 | 0 | 1 | <3/Neg | <3/Neg | <3/Neg | <3/Neg | <3/Neg |
46, M | no | 4 | 0,8 | 1 | 0 | 1 | 0 | 1 | 3 | 0 | 1 | 3,47 | <3/Neg | <3/Neg | <3/Neg | <3/Neg |
46, M | no | 13 | 0,4 | 1 | 1 | 0 | 1 | 1 | 4 | 1 | 1 | 5,3 | <3/Neg | <3/Neg | <3/Neg | <3/Neg |
45, F | 12 yo | 16 | 0,6 | 1 | 1 | 1 | 0 | 1 | 4 | 1 | 1 | 47,74 | <3/Neg | 36,43 | <3/Neg | <3/Neg |
48, M | no | 8 | 0,5 | 1 | 1 | 0 | 0 | 1 | 3 | 0 | 1 | 104,38 | <3/Neg | <3/Neg | <3/Neg | <3/Neg |
28, M | no | 16 | 0,5 | 1 | 0 | 0 | 1 | 1 | 3 | 0 | 1 | 6,49 | <3/Neg | <3/Neg | <3/Neg | <3/Neg |
46, F | 12 yo | 5 | 0,6 | 1 | 1 | 1 | 0 | 1 | 4 | 0 | 1 | 5,55 | <3/Neg | <3/Neg | <3/Neg | <3/Neg |